Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Discover the key Worldwide Dividend ETF Options you should consider for an income-focused portfolio. Learn how to compare dividend yields and risk profiles.
13,773 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
As markets enter the midyear phase of 2026, three proven compounders highlight why patient investing still works. App...
Vodafone Group shares jumped about 13% after a dramatic stake reshuffle that makes Vega the largest shareholder. The ...
The global ship lease (gsl) market rides waves of charter rates and fleet utilization. This guide breaks down how gsl...
Valero Energy posts a 98% capacity utilization for 2025, expands its dividend, and exits California, fueling a fresh ...
Two oil giants enter 2026 with contrasting plays: Occidental Petroleum pares back, focusing on the Permian, while Exx...
Two defense giants, two paths to growth. This guide breaks down Lockheed Martin and RTX, outlining which offers more ...
Visa and Mastercard operate the core rails of digital payments. Both offer durable moats, steady cash flow, and limit...
When a large investor opens million position in an industrial REIT, it signals confidence in long-term cash flow and ...
A sudden explosion at Valero’s Port Arthur refinery prompted a temporary shutdown, sending ripples through energy mar...
Investors face a pivotal choice in 2026: a dependable defense powerhouse or a cyclical recovery in commercial aviatio...
While Nvidia grabs the spotlight with GPUs, Broadcom quietly powers AI at scale with custom accelerators. This articl...